Medical information provider Wolters Kluwer Health (WK Health), US, has introduced a new market research service, Wolters Kluwer Health inThought. The service was developed to help financial analysts, health care suppliers and drug makers understand where developmental drugs, medical devices and therapies are positioned today and where they are likely headed in the future.
inThought is among the first of a new generation of research services that can deliver data, analysis and forecasting from a single source, an approach that is both cost effective and helps streamline the market research process. It integrates WK Health's trusted clinical, prescription, managed markets and patient information together with the keen insight and forecasting abilities developed by a team of skilled individuals including researchers, analysts and physicians.
inThought research and analysis is available to customers through products such as research alerts geared toward specific customer requirements; subscriptions to a powerful, Web-based drug pipeline database that integrates inThought forecasts with detailed monitoring of drug development programmes around the world; regular conference calls to connect customers with medical experts providing the physician perspective; revenue forecasts and probability of approval models for over 300 drugs in development; syndicated research reports that delve deep into specific markets; and custom research projects and counsel designed to meet individual customer needs.
Search for more such STM tools/services/products in K-Store
Discuss this NEWS
